211 related articles for article (PubMed ID: 34387119)
21. A prospective observational cohort study examining the development of head and neck lymphedema from the time of diagnosis.
Pigott A; Brown B; White N; McPhail S; Porceddu S; Liu H; Jeans C; Panizza B; Nixon J
Asia Pac J Clin Oncol; 2023 Aug; 19(4):473-481. PubMed ID: 36101931
[TBL] [Abstract][Full Text] [Related]
22. Quality assessment of PBM protocols for oral complications in head and neck cancer patients: part 2.
Gobbo M; Arany PR; Merigo E; Bensadoun RJ; Santos-Silva AR; Gueiros LA; Ottaviani G
Support Care Cancer; 2023 Apr; 31(5):306. PubMed ID: 37115315
[TBL] [Abstract][Full Text] [Related]
23. Lymphedema outcomes in patients with head and neck cancer.
Smith BG; Hutcheson KA; Little LG; Skoracki RJ; Rosenthal DI; Lai SY; Lewin JS
Otolaryngol Head Neck Surg; 2015 Feb; 152(2):284-291. PubMed ID: 25389318
[TBL] [Abstract][Full Text] [Related]
24. Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life.
Deng J; Murphy BA; Dietrich MS; Wells N; Wallston KA; Sinard RJ; Cmelak AJ; Gilbert J; Ridner SH
Head Neck; 2013 Jul; 35(7):1026-35. PubMed ID: 22791550
[TBL] [Abstract][Full Text] [Related]
25. Submental liposuction for the management of lymphedema following head and neck cancer treatment: a randomized controlled trial.
Alamoudi U; Taylor B; MacKay C; Rigby MH; Hart R; Trites JRB; Taylor SM
J Otolaryngol Head Neck Surg; 2018 Mar; 47(1):22. PubMed ID: 29580298
[TBL] [Abstract][Full Text] [Related]
26. A Prospective Study of the Lymphedema and Fibrosis Continuum in Patients with Head and Neck Cancer.
Ridner SH; Dietrich MS; Niermann K; Cmelak A; Mannion K; Murphy B
Lymphat Res Biol; 2016 Dec; 14(4):198-205. PubMed ID: 27305456
[TBL] [Abstract][Full Text] [Related]
27. Assessment of external lymphedema in patients with head and neck cancer: a comparison of four scales.
Deng J; Ridner SH; Dietrich MS; Wells N; Murphy BA
Oncol Nurs Forum; 2013 Sep; 40(5):501-6. PubMed ID: 23989023
[TBL] [Abstract][Full Text] [Related]
28. Preliminary development of a lymphedema symptom assessment scale for patients with head and neck cancer.
Deng J; Ridner SH; Murphy BA; Dietrich MS
Support Care Cancer; 2012 Aug; 20(8):1911-8. PubMed ID: 22072048
[TBL] [Abstract][Full Text] [Related]
29. Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial).
Robijns J; Lodewijckx J; Claes S; Van Bever L; Pannekoeke L; Censabella S; Bussé L; Colson D; Kaminski I; Broux V; Puts S; Vanmechelen S; Timmermans A; Noé L; Bulens P; Govers M; Maes A; Mebis J
Radiother Oncol; 2021 May; 158():268-275. PubMed ID: 33711412
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with external and internal lymphedema in patients with head-and-neck cancer.
Deng J; Ridner SH; Dietrich MS; Wells N; Wallston KA; Sinard RJ; Cmelak AJ; Murphy BA
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e319-28. PubMed ID: 22652102
[TBL] [Abstract][Full Text] [Related]
31. Preliminary evaluation of reliability and validity of head and neck external lymphedema and fibrosis assessment criteria.
Deng J; Dietrich MS; Ridner SH; Fleischer AC; Wells N; Murphy BA
Eur J Oncol Nurs; 2016 Jun; 22():63-70. PubMed ID: 27179894
[TBL] [Abstract][Full Text] [Related]
32. Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review.
Baxter GD; Liu L; Petrich S; Gisselman AS; Chapple C; Anders JJ; Tumilty S
BMC Cancer; 2017 Dec; 17(1):833. PubMed ID: 29216916
[TBL] [Abstract][Full Text] [Related]
33. Progressive resistance training in cachectic head and neck cancer patients undergoing radiotherapy: a randomized controlled pilot feasibility trial.
Grote M; Maihöfer C; Weigl M; Davies-Knorr P; Belka C
Radiat Oncol; 2018 Nov; 13(1):215. PubMed ID: 30400971
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of a Pilot Randomized Controlled Trial Examining a Multidimensional Intervention in Women with Gynecological Cancer at Risk of Lymphedema.
Shallwani SM; Towers A; Newman A; Salvador S; Yung A; Gilbert L; Gotlieb WH; Zeng X; Thomas D
Curr Oncol; 2021 Jan; 28(1):455-470. PubMed ID: 33450972
[TBL] [Abstract][Full Text] [Related]
35. Feasibility and Preliminary Efficacy of Tailored Yoga in Survivors of Head and Neck Cancer: A Pilot Study.
Adair M; Murphy B; Yarlagadda S; Deng J; Dietrich MS; Ridner SH
Integr Cancer Ther; 2018 Sep; 17(3):774-784. PubMed ID: 29355046
[TBL] [Abstract][Full Text] [Related]
36. Perceived Symptom Experience in Head and Neck Cancer Patients with Lymphedema.
Deng J; Ridner S; Rothman R; Murphy B; Sherman K; Moore L; Hall K; Weiner B
J Palliat Med; 2016 Dec; 19(12):1267-1274. PubMed ID: 27617837
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Factors and Outcomes Associated With Neck Lymphedema in Head and Neck Cancer Survivors.
Lao IJ; Berry J; Li J; Balogun Z; Elgohari B; Skinner H; Johnson J; Nilsen ML
Laryngoscope; 2024 Mar; ():. PubMed ID: 38501703
[TBL] [Abstract][Full Text] [Related]
38. Usability of advanced pneumatic compression to treat cancer-related head and neck lymphedema: A feasibility study.
Mayrovitz HN; Ryan S; Hartman JM
Head Neck; 2018 Jan; 40(1):137-143. PubMed ID: 29131439
[TBL] [Abstract][Full Text] [Related]
39. Prospective trial of complete decongestive therapy for upper extremity lymphedema after breast cancer therapy.
Mondry TE; Riffenburgh RH; Johnstone PA
Cancer J; 2004; 10(1):42-8; discussion 17-9. PubMed ID: 15000494
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal effects of a novel advanced pneumatic compression device on patient-reported outcomes in the management of cancer-related head and neck lymphedema: A preliminary report.
Gutiérrez C; Mayrovitz HN; Naqvi SHS; Karni RJ
Head Neck; 2020 Aug; 42(8):1791-1799. PubMed ID: 32187788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
